醫藥品賦形劑的美國市場（∼2015年） 是由出版商The Freedonia Group在2011年05月所出版的。
這份英文市場調查報告書包含281 Pages 價格從美金4800起跳。
2010年達15億美金的美國醫藥品賦形劑的需求、預計在2015年會達20億美金。此成長因素為、此國家的醫藥品製造的增加及、所改良的賦形劑之製劑的重要性提升等。
本報告書內容包括:美國的醫藥品賦形劑（添加劑）市場的實績資料（2000年、2005年、2010年）和、2015年及2020年的各產品、各種應用的預測之提供、主要市場環境因素、主要企業的佔有率和介紹等資訊、內容綱要摘記如下:
第1章 實施摘要
第2章 市場環境
- 概要
- 經濟因素
- 人口動態的模式
- 醫療照護的趨勢
- 醫藥品業界
- 市場的實績資料
- 海外貿易
- 國際市場
第3章 產品
- 概要
- 聚合物
- 酒精
- 礦物質
- 明膠
- 糖
- 其他醫藥品賦形劑
第4章 應用
- 概要
- 填充料／稀釋劑
- 結合劑
- 懸濁劑／黏性劑
- 塗層
- 流動促進劑
- 香料賦形劑
- 膠囊
- 錠劑分解物質
- 著色料
- 潤滑劑
- 保存料
- 其他
第5章 產業構造
- 概要
- 市場佔有率
- 競爭構造
- M&A
- 專利及相關契約
- 行銷及物流
- 研究開發
- 製造
企業介紹
圖表
Abstract
US demand to approach $2 billion in 2015
US demand for pharmaceutical excipients is expected to approach $2 billion in
2015, driven by growing production of pharmaceuticals in the US and the
increasing importance of improved excipients in drug formulations.
Pharmaceutical companies are emphasizing the use and development of new and/or
improved inactive ingredients in response to the growing problems of patent
expirations for key products, increasing competition from foreign suppliers
and downward pricing pressure from end users. Of particular interest to
pharmaceutical companies is the development of new, patentable proprietary
formulations that can be used to compete with generic products. Excipients can
be used to provide more convenient dosage formats and are important to
maintaining the efficacy, stability, safety and longevity of medicines.
New, patentable applications for excipients to spur growth
Pharmaceutical companies are increasingly interested in developing new,
patentable proprietary drugs that can be used to compete with generic
formulations. Once only fillers and conduits for active ingredients,
excipients are now used to provide more convenient dosage forms, to deliver
drugs effectively, to control the timing of release (delayed, immediate), and
to provide immediate disintegration in special circumstances. Their importance
in drug delivery, safety, stability, efficacy and convenience can be crucial
to patient compliance. Growth opportunities will extend to a wide range of
compounds and applications. Cellulosic materials will remain the dominant
materials for excipient fillers, but will expand sales through specialty
combination of excipients to improve and reduce the costs of tableting.
Gelatin will remain the leading compound for encapsulation based on continued
solid performance and safety, withstanding challenges from more expensive
cellulosic and vegetable oil derivative alternatives, but will be used
increasingly to encapsulate granules of active ingredients and to improve
coatings. Lactose, used most often as a filler, is now being developed as an
inhalant for drug delivery. Other products are under development that can
deliver active ingredients to specific places in the body, or improve the
release of newly developed medicines that do not break down in water.
Combined materials improve quality and reduce costs
Excipient producers are marketing combination materials that, together,
improve overall performance in producing finished tablets of higher quality at
reduced cost. Cellulosic excipients will experience significant growth through
2015 due to the development of co-processed materials that combine properties
of compressibility and flowability. Composites of microcrystalline cellulose
(MCC), hydroxypropyl methylcellulose (HPMC) and Corpovidone (CPVD) are
engineered for binding, filling and disintegrating capabilities that exceed
the quality of action in individual excipients, and ensure product
consistency. MCC will see particularly strong growth because of its capacity
for use in direct compression in tableting -- a process that is substantially
less expensive than the more standard wet granulation process for the same
purpose. Multifunctional synthetic polymers such as polyethylene glycol (PEG)
and povidone will continue to experience strong growth because of their broad
application for high value-added oral medicines, including their use for
controlled release and disintegration.
Study coverage
|
This new Freedonia US industry study, “Excipients”, presents
historical demand data (2000, 2005 and 2010) plus forecasts for 2015 and 2020
by excipient product and application. The study also considers key market
environment factors, assesses industry structure, evaluates company market
share and profiles 60 industry competitors.
|
This study can help you:
- Determine your market & sales potential
- Learn more about industry competitors
- Assess new products & technologies
- Identify firms to merge with or acquire
- Complement your research & planning
- Gather data for presentations
- Confirm your own internal data
- Make better business decisions
Freedonia's methods involve:
- Establishing consistent economic and market forecasts
- Using input/output ratios, flow charts and other economic methods to
quantify data
- Employing in-house analysts who meet stringent quality standards
- Interviewing key industry participants, experts and end users
- Researching a proprietary database that includes trade publications,
government reports and corporate literature
Table of Contents
INTRODUCTION
I. EXECUTIVE SUMMARY
II. MARKET ENVIRONMENT
- General
- Economic Factors
- Demographic Patterns
- Health Care Trends
- National Health Expenditures
- Medical Conditions
- Chronic Conditions
- Acute Conditions
- Pharmaceuticals
- Therapeutic Class
- Dosage Formulations
- Distribution Classifications
- Historical Market Trends
- Foreign Trade
- International Markets
III. PRODUCTS
- General
- Polymers
- Cellulose Derivatives
- Microcrystalline Cellulose (MCC)
- Hydroxypropyl Methylcellulose (HPMC)
- Ethyl Cellulose
- Methyl Cellulose
- Carboxymethylcellulose (CMC)
- Croscarmellose Sodium
- Other Cellulose Excipients
- Povidone
- Starch Compounds
- Pregelatinized Starch
- Sodium Starch Glycolate
- Other Starch Excipients
- Polyethylene Glycol
- Acrylic Polymers
- Other Polymers
- Natural Gums from Seaweeds
- Other Plant-Based Natural Gums
- Synthetic Polymers
- Alcohols
- Glycerin
- Propylene Glycol
- Sorbitol
- Other Alcohols
- Mannitol
- Other Polyol Excipients
- All Other Alcohols
- Minerals
- Calcium Phosphate
- Calcium Carbonate
- Mineral Hydrocarbons
- Clay
- Silicon Dioxide
- Titanium Dioxide
- Other Minerals
- Gelatin
- Sugars
- Lactose
- Sucrose
- Other Sugar Excipients
- Other Pharmaceutical Excipients
- Dyes & Pigments
- Flavors
- Surfactants
- Acidulants
- Antioxidants
- Stearate Compounds
- All Other Compounds
- Electrolytes & Related Compounds
- Chemical Plasticizers
- High Intensity Sweeteners
- Natural Fats, Oils & Waxes
IV. APPLICATIONS
- General
- Fillers & Diluents
- Binders
- Suspension & Viscosity Agents
- Coatings
- Solvents
- Flavoring Agents
- Capsules
- Disintegrants
- Colorants
- Lubricants & Glidants
- Preservatives
- Other Applications
V. INDUSTRY STRUCTURE
- General
- Market Share
- Competitive Strategies
- Selected Mergers & Acquisitions
- Selected Licensing & Related Agreements
- Marketing & Distribution
- Research & Development
- Manufacturing
Company Profiles
- ABITEC, see Associated British Foods
- Akzo Nobel NV
- Archer-Daniels-Midland Company
- Ashland Incorporated
- Associated British Foods plc
- AVANTOR Performance Materials
- BASF SE
- Berwind Corporation
- Cabot Corporation
- Cargill Incorporated
- Celanese Corporation
- Cognis Holding, see BASF
- Colorcon, see Berwind
- Corn Products International Incorporated
- Covidien plc
- CP Kelco, see Huber (JM)
- Croda International plc
- CyDex Pharmaceuticals, see Ligand Pharmaceuticals
- Danisco A/S
- Dow Chemical Company
- Eastman Chemical Company
- EMD Chemicals, see Merck
- Evonik Industries AG
- Ferro Corporation
- FibroGen Incorporated
- Flavorx Incorporated
- FMC Corporation
- GELITA AG
- Generichem Corporation
- Huber (JM) Corporation
- Huntsman Corporation
- Innophos Incorporated
- International Specialty Products Incorporated
- JRS Pharma, see Rettenmaier (J.) & Sohne
- Kraft Foods Incorporated
- Kuraray Company Limited
- Ligand Pharmaceuticals Incorporated
- Lubrizol Corporation
- LyondellBasell Industries NV
- Mallinckrodt Baker, see AVANTOR Performance Materials
- Merck KGaA
- Mutchler Incorporated
- National Starch, see Corn Products International
- Nitta Gelatin Incorporated
- NutraSweet Company
- Nutrinova Nutrition Specialties & Food Ingredients, see Celanese
- P&G Chemicals, see Procter & Gamble
- PB Gelatins, see Tessenderlo Group
- Procter & Gamble Company
- Rettenmaier (J.) & Sohne GmbH & Company KG
- Roquette Freres SA
- Royal Dutch Shell plc
- Sasol Limited
- Shin-Etsu Chemical Company Limited
- Solvay SA
- SPI Pharma, see Associated British Foods
- Stepan Company
- Tate & Lyle plc
- Tessenderlo Group NV
- USG Corporation
- Wacker Chemie AG
- Other Companies Involved in the US Excipients Industry
LIST OF TABLES
SECTION I -- EXECUTIVE SUMMARY
SECTION II -- MARKET ENVIRONMENT
- Macroeconomic Indicators
- Population & Households
- National Health Expenditures
- Chronic Conditions by Type
- Acute Conditions by Type
- Pharmaceutical Supply & Demand
- Pharmaceutical Shipments by Therapeutic Class
- Pharmaceutical Shipments by Dosage Formulation
- Pharmaceutical Shipments by Distribution Classification
- Excipient Market, 2000-2010
SECTION III -- PRODUCTS
- Pharmaceutical Excipient Demand by Product Group
- Polymer Excipient Demand by Type
- Cellulose Excipient Demand by Type
- Microcrystalline Cellulose Excipient Demand by Application
- Hydroxypropyl Methylcellulose Excipient Demand by Application
- Ethyl Cellulose Excipient Demand by Application
- Methyl Cellulose Excipient Demand by Application
- Carboxymethylcellulose Excipient Demand by Application
- Croscarmellose Sodium Excipient Demand by Application
- Other Cellulose Excipient Demand by Application
- Povidone Excipient Demand by Application
- Starch Excipient Demand by Type
- Pregelatinized Starch Excipient Demand by Application
- Sodium Starch Excipient Demand
- Other Starch Excipient Demand by Application
- Polyethylene Glycol Excipient Demand by Application
- Acrylic Polymer Excipient Demand by Application
- Other Polymer Excipients by Application
- Alcohol Excipient Demand by Type
- Glycerin Excipient Demand by Application
- Propylene Glycol Excipient Demand by Application
- Sorbitol Excipient Demand by Application
- Other Alcohol Excipient Demand by Type & Application
- Mineral Excipient Demand by Type
- Calcium Phosphate Excipient Demand
- Calcium Carbonate Excipient Demand
- Mineral Hydrocarbon Excipient Demand by Application
- Clay Excipient Demand by Application
- Silicon Dioxide Excipient Demand by Application
- Titanium Dioxide Excipient Demand
- Other Mineral Excipient Demand by Application
- Gelatin Excipient Demand by Application
- Sugar Excipient Demand by Type
- Lactose Excipient Demand by Application
- Sucrose Excipient Demand by Application
- Other Sugar Excipient Demand
- Other Pharmaceutical Excipients Demand by Type & Application
SECTION IV -- APPLICATIONS
- Pharmaceutical Excipient Demand by Application
- Filler & Diluent Excipient Demand by Type
- Binder Excipient Demand by Type
- Suspension & Viscosity Excipient Demand by Type
- Coating Excipient Demand by Type
- Solvent Excipient Demand by Type
- Flavoring Agent Excipient Demand by Type
- Capsule Excipient Demand by Type
- Disintegrant Excipient Demand by Type
- Colorant Excipient Demand by Type
- Lubricant & Glidant Excipient Demand by Type
- Preservative Excipient Demand by Type
- Other Applications for Excipients by Type
SECTION V -- INDUSTRY STRUCTURE
- US Excipient Sales by Company, 2010
- Selected Acquisitions & Divestitures
- Selected Cooperative Agreements
LIST OF CHARTS
SECTION III -- PRODUCTS
- Pharmaceutical Excipient Demand by Product Group, 2010
- Polymer Excipient Demand by Type, 2010
SECTION IV -- APPLICATIONS
- Pharmaceutical Excipient Demand by Application, 2010
SECTION V -- INDUSTRY STRUCTURE
- US Excipient Market Share by Company, 2010
|
